Explore Inovio Pharmaceuticals' Q2 2025 earnings call highlights, including progress on INO-3107, regulatory milestones, financial updates, and ...

Merck KGaA is in the investment-grade market Tuesday, a day after holding investor calls, to help fund its $3.9 billion ...

Immunome's varegacestat shows promising efficacy in desmoid tumors, with phase 3 topline data expected by 2025-end. Read why ...

Mount Gambier hosts a full 12-race program this Sunday, August 10, 2025, with the first event jumping at 12:42pm AEST. The meeting offers a mix of maiden, g ...

In Q2 2025, the global pharma sector experienced a decline in M&A activity, with deals worth $32.9 billion, down 11.6% from Q1. Deal volume fell 12.8% to 130. Oncology led with 51 deals. Discover key ...

Merck & Co., Inc. (NYSE: MRK) is one of the best depressed stocks to buy in 2025. On August 2, the company completed the ...

Germany's Merck KGaA on Thursday raised its full-year operating earnings guidance, excluding the effect of harsh foreign ...

Merck KGaA closed the divestment of its global Surface Solutions business to Global New Material International Holdings Ltd. ...

Now a summer staple in Stratford, the World in a Weekend: International Puppet Festival is pushing itself to the limit by adding a fifth day of programming while welcoming performers from all corners ...

The second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors like escalating policy pressures, pipeline pivots by leading companies and the ...